Cardiogenetics
September 10, 2026
Can Polygenic Risk Scores Uncover Hidden CVD? September 10, 2026
It’s rare that one gene causes CVD, just as it’s rare for one CV condition to occur in isolation. In a recent JACC issue, researchers show that […]
Cardiology Pharmaceuticals
September 10, 2026
Novo, Novartis, and How Two Trials Cast Doubt on CVD Biomarkers September 10, 2026
Cardiology just took back-to-back blows to two of its most promising prevention strategies. One drug for lowering lipoprotein(a) and another targeting interleukin-6 both failed in major trials, even as fresh data reaffirms just how much those factors matter.
Surgeries & Interventions
September 3, 2026
A Tale of Two Studies and the Importance of Patient Selection September 3, 2026
Two recent studies are forcing an important conversation in cardiology – some of the field's most common procedures may not be as clearly beneficial as open-label data originally suggests.
